Case Report
A Rare Case of Breast Implant-Associated Diffuse Large B-Cell Lymphoma
Table 1
A listing of DLBCL diagnostic markers [
4,
6].
| Biomarker expression/genetic alterations | Percentage of cases |
| CD19, CD20, CD22, CD79A, CD45 | Pan B-cell antigens, highly expressed | CD30 | 25% (anaplastic variant) | BCL2 | 25-80% | BCL6 | 70% | CD10 | 30-60% | MUM1/IRF4 | 35-65% | CD5 | Uncommon, aggressive disease | (14;18) translocation | 30% | MYC gene rearranged | 5-15% |
|
|